The short version
- Why people research itScalp DHT reduction for pattern hair loss, and prostate volume in BPH — a 5-alpha-reductase inhibitor. Sexual side effects are the documented concern and are covered on the page.
- What the evidence isLarge randomized trials support it for androgenetic alopecia and benign prostatic hyperplasia.
- What to watchSexual symptoms or low mood that persist after stopping.
How Finasteride works
Finasteride does not lower testosterone. It blocks one enzyme that converts testosterone into something more potent, and the whole clinical picture — benefit and harm together — comes from which isoform of that enzyme it blocks and which tissues carry it.
The enzyme and its two isoforms. Steroid 5-alpha-reductase reduces testosterone to dihydrotestosterone. DHT binds the androgen receptor with several-fold higher affinity than testosterone and dissociates more slowly, so it is the more powerful ligand at the same concentration.
- Oral
On the goal map: 5-alpha-reductase, DHT & the hair trade-off (Testosterone & the male hormonal axis)
Research on Finasteride6 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Large randomized trials support it for androgenetic alopecia and benign prostatic hyperplasia. The PCPT trial in over 18,000 men found reduced overall prostate cancer incidence with an apparent increase in high-grade disease — later analyses attributed much of that to detection bias in smaller prostates.
Post-finasteride syndrome is the live controversy. Persistent sexual and neurological symptoms after discontinuation are reported in the literature and acknowledged on the label in several countries; whether it is a distinct entity and how common it is remain genuinely unsettled.
Correlative data
Very heavy real-world use with a bimodal reported experience — the large majority report no issues, a minority report significant and sometimes persistent effects. Both of those are true at once and neither cancels the other.
It halves PSA, so any PSA result must be doubled and the prescriber told.
How the mechanism reads
A 5-alpha-reductase type 2 inhibitor, blocking conversion of testosterone to DHT — the androgen driving both follicular miniaturization and prostate growth.
Mechanistic5-alpha-reductase also produces neurosteroids such as allopregnanolone, which act on GABA-A receptors. That is the most plausible mechanistic account of the mood and cognitive symptoms a minority report, and it is why the topical route is of interest — less systemic enzyme inhibition.
Mechanistic
Sources
- U.S. Food and Drug Administration. DailyMed, U.S. National Library of Medicine; label revised 2022
- Zhang JJ, et al. Sexual, physical, and overall adverse effects in patients treated with 5alpha-reductase inhibitors: a systematic review and meta-analysis. Asian Journal of Andrology 2022 · PMID 34747724
- Zhou C, et al. Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study. Chinese Medical Journal 2025 · PMID 40090937
Finasteride safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Pregnancy, or a partner who is pregnant handling crushed tablets, because DHT shapes male fetal genitals.
- A past of depression or suicidal thoughts, since mood effects are reported.
- PSA screening without correcting for the roughly halved reading.
- Male breast cancer history.
- Under 18, since DHT is needed for normal male genital development.
What’s expected
- DHT falls by about two thirds, which halts follicle miniaturization in most men.
- Lower libido or erectile difficulty in a minority.
- PSA falls by about half within the first year.
Watch for
- Sexual symptoms or low mood that persist after stopping.
- Thoughts of self-harm.
- A breast lump or nipple discharge.
Labs that tell you it’s working
- Total DHT & Free DHT: the direct target, expected to fall sharply.
- PSA Total + Free + % Free: reset the baseline after six to twelve months or the screening is blind.
- Total & Free Testosterone: rises slightly as less is converted.
- Estradiol: the spared testosterone can aromatize upward.
Type 2 5-alpha-reductase inhibitor cutting DHT by roughly two thirds; sexual and mood effects are the documented adverse signal. PMID 34747724 PMID 40090937
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
The “Low T? Rule Out the Reversible Causes First” panel, explained
Finasteride FAQ4 common questions
- Is Finasteride approved for human use?
- No. Finasteride is a research compound.
- What is Finasteride researched for?
- Scalp DHT reduction for pattern hair loss, and prostate volume in BPH — a 5-alpha-reductase inhibitor. Sexual side effects are the documented concern and are covered on the page.
- Which labs show whether it's doing anything?
- Total DHT & Free DHT; PSA Total + Free + % Free; Total & Free Testosterone; Estradiol: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Finasteride: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



